Carma Fund
3 rounds tracked since 11 June 2025.
- Rounds
- 3
- Led
- 0
- Capital in these rounds
- $85.2M
Sectors
Countries
Rounds
- ExcivaDevelops drugs for behavioral symptoms of Alzheimer's disease $59.8MSeries B · 20 Jan
- TECregenBiologics to regenerate the thymus and restore T-cell immunity $12.5MSeed · 8 Jan
- ElkedoniaDevelops non-hallucinogenic neuroplastogens for treatment-resistant depression $12.9MSeed · 11 Jun
No round matches these filters.